Maiwald Magazine

News and Releases

Maiwald Blog

9 Dec 2025 - Maiwald Blog

New fee schedule for the Unified Patent Court (UPC) from 1 January 2026

The Administrative Committee of the UPC has decided on a comprehensive reform of court fees, which will come into force on 1 January 2026. The adjustment affects almost all fe...

Continue reading

4 Nov 2025 - Maiwald Blog

Why Patent Defense and Military Technologies?

When developing high-tech technologies for use in defense and military applications, you might wonder whether patent protection is necessary. Even though your customer base is...

Continue reading

26 May 2025 - Maiwald Blog

Turn one into several – what Rule 80 EPC says about using several independent claims to defend one independent claim

The Board of Appeal of the EPO has issued two decisions concerning appeal cases T 0123/22 and T 1191/22, which relate to the interpretation of Rule 80 EPC. The fundamental que...

Continue reading

All articles

Press Coverage

5 Dec 2025 - Press Coverage

Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement.

Royalty Pharma and Denali have entered into a $275 million financing agreement which, pursuant to a synthetic royalty agreement, is based on future net sales of tividenofusp alfa. Tividenofusp alfa is Denali’s lead investigational TransportVehicle™-enabled enzyme rep...

Continue reading

25 Aug 2025 - Press Coverage

Royalty Pharma acquires licence interest for Amgen’s Imdelltra – Maiwald advises on transaction

Royalty Pharma has acquired a royalty interest in Amgen's Imdelltra, an innovative BiTE antibody for the treatment of small cell lung cancer, from BeOne Medicines for an upfront payment of $885 million. The agreement allows BeOne to sell additional royalty rights in Imdelltr...

Continue reading

14 Jul 2025 - Press Coverage

Royalty Pharma and Revolution Medicines Sign Funding Agreements Worth Up to $2 Billion

Royalty Pharma plc and Revolution Medicines, Inc. have announced a strategic funding collaboration of up to $2 billion to support the global development and commercialization of Revolution’s RAS(ON) inhibitor portfolio, particularly the clinical advancement of lead candida...

Continue reading

Maiwald in the press

Staff News

2 Mar 2026 - Staff News

Maiwald appoints Dr. Kerstin Wolff as Partner

Maiwald, one of Germany’s leading intellectual property law firms, has appointed Dr. Kerstin Wolff as Partner effective from 1 March 2026. This appointment further strengthe...

Continue reading

29 Jan 2026 - Staff News

Maiwald appoints Martina Boidol, Dr. Anja Fux, and Sebastian Herzog as managing partners

With retroactive effect from the beginning of the new year, Maiwald, one of Germany's leading intellectual property law firms, has appointed Martina Boidol, Dr. Anja Fux, and ...

Continue reading

11 Nov 2025 - Staff News

Dr Iris Müller and Dr Gabriel Kiefl sworn in as German patent attorneys

We are pleased to announce that our colleagues

Continue reading

All Staff News

Publications

19 Mar 2026 - Publication

Clinical Trial Inventions in the Squeeze: The New Transparency Rules for Clinical Trials in the EU and the Assessment of Patentability by the EPO and the UPC, epi information, 1/2026

The article examines how the EU’s new transparency framework for clinical trials affects patentability assessments for inventions arising in the clinical phase. From both a ...

Continue reading

13 Mar 2026 - Publication

Patent handbooks published by Maiwald attorneys

Handbook Pharmaceutical, Biological and Chemical Patents To order these books at a special discount...

Continue reading

12 Mar 2026 - Publication

Podcast: „From idea to IP: navigating AI patents in a fast-moving field“

New podcast: “From idea to IP: navigating AI patents in a fast-moving field” How can AI inventions be successfully pat...

Continue reading

All publications

Awards

25 Mar 2026 - Award

The Legal 500 EMEA 2026: Maiwald recommended in three practice areas

The Legal 500, one of the world’s leading legal directories, has once again recommended Maiwald in the EMEA 2026 edition. Our firm is recognized in the following categories:...

Continue reading

12 Mar 2026 - Award

Maiwald recognized by FOCUS as a Top Medium-Sized Employer 2026

At Maiwald, we continuously strive to create a work environment where all colleagues feel welcome—with a clear focus on feedback, development, and positive collaboration. We...

Continue reading

19 Feb 2026 - Award

Chambers Germany 2026 Rankings

We are proud that Chambers & Partners has once again recognized Maiwald in its Germany 2026 guide — with

Continue reading

All awards

Events

Wed.

8

8 Apr 2026 |Upcoming

Maiwald at the 33rd Annual IP Conference of the Fordham IP Institute in New York

The 33rd Annual IP Law & Policy Conference of the renowned Fordham Intellectual Property Institute will take place from 8 to 10 April 2026 at Fordham Law School in New York. This year’s program has been expanded to 2.5 days, with new sessions starting on Wednesday afternoon. The conference brings together leading a...

Continue reading

Thu.

23

23 Apr 2026 |Upcoming

Maiwald at AI & IP Forum 2026 in Munich | 23rd April

Maiwald will participate in the AI & IP Forum 2026 in Munich. The in‑person conference will take place on 23 April 2026 and brings together professionals from patent offices, industry and private practice to discuss current developments at the intersection of artificial intelligence and intellectual property. We are pleased that

Continue reading

Thu.

23

23 Apr 2026 |Upcoming

VPP Spring Conference 2026: Maiwald on site in Dortmund

The VPP Spring Conference will take place on 23–24 April 2026 at Kongress Dortmund. Over two days, the program will address current developments in intellectual property, combining high‑level presentations with practice‑oriented discussions and in‑person networking. Key topics include: ...

Continue reading

Sun.

26

26 Apr 2026 |Upcoming

LESI 2026 Annual Conference in Dublin | April 26th-29th

Maiwald will once again participate in the LESI Annual Conference in 2026. “LESI 2026 – INNOVATION TO IMPACT: IP as an International Growth Engine” will take place on 26–29 April and will bring together leading minds and decision-makers in Dublin to showcase how intellectual property serves as an...

Continue reading

All events